Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-03 FOUSE JACQUALYN A Director Grant or award · Stock option (right to buy) +16,000 16,000
2017-12-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 38,837
2017-12-01 Schenkein David P Chief Executive Officer Option exercise +6,000 $0.30 $2K 6,000
2017-12-01 Schenkein David P Chief Executive Officer Sale −5,600 $61.51 $344K 400
2017-12-01 Schenkein David P Chief Executive Officer Sale −400 $62.08 $25K 0
2017-12-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −6,000 20,656
2017-12-01 Biller Scott Chief Scientific Officer Option exercise +2,146 $31.64 $68K 8,410
2017-12-01 Biller Scott Chief Scientific Officer Sale −600 $59.89 $36K 7,810
2017-12-01 Biller Scott Chief Scientific Officer Sale −846 $60.63 $51K 6,964
2017-12-01 Biller Scott Chief Scientific Officer Sale −700 $61.76 $43K 6,264
2017-12-01 Biller Scott Chief Scientific Officer Option exercise · Stock options (right to buy) −2,146 30,039
2017-11-14 Cantley Lewis Clayton Jr. Director Sale −691 $59.36 $41K 81,703
2017-11-14 Cantley Lewis Clayton Jr. Director Sale −691 $59.36 $41K 81,743
2017-11-14 Cantley Lewis Clayton Jr. Director Sale −309 $60.46 $19K 81,394
2017-11-14 Cantley Lewis Clayton Jr. Director Sale −309 $60.46 $19K 81,434
2017-11-13 Cantley Lewis Clayton Jr. Director Sale −1,000 $62.07 $62K 82,394
2017-11-13 Cantley Lewis Clayton Jr. Director Sale −1,000 $62.07 $62K 82,434
2017-11-01 Biller Scott Chief Scientific Officer Option exercise +2,146 $31.64 $68K 8,410
2017-11-01 Biller Scott Chief Scientific Officer Sale −100 $65.45 $7K 8,310
2017-11-01 Biller Scott Chief Scientific Officer Sale −200 $63.62 $13K 8,110

Page 70 of 80 · 1,590 trades